Accretion Pharmaceuticals Limited IPO

Accretion Pharmaceuticals Limited is listed in the SME segment with a price band of ₹96 to ₹101. The figures below are as reported by the exchanges and public sources.

Accretion Pharmaceuticals Limited IPO — key facts

• The Accretion Pharmaceuticals Limited IPO price band is ₹96 to ₹101 per share.
• As of 5 September 2026, the Accretion Pharmaceuticals Limited IPO subscription status is 7.67x overall.
• The issue is open from 14-MAY-2025 to 16-MAY-2025.
• Accretion Pharmaceuticals Limited listed on 21-MAY-2025.
• Accretion Pharmaceuticals Limited listed at ₹82.95. The listing loss was 17.9% against the upper end of the issue price band.

Accretion Pharmaceuticals Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹96 – ₹101

Issue size

₹29.75 Cr

Fresh issue

₹28.26 Cr

Opens

14-MAY-2025

Closes

16-MAY-2025

Listing

21-MAY-2025

Total subscription

7.67x

Retail

10.54x

QIB

12.14x

NII

4.28x

Lead managers

Jawa Capital

Listing price

₹82.95

Listing day change

-17.9%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.